Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Jenna Burton

Concepts (185)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Dog Diseases
25
2025
140
6.550
Why?
Cat Diseases
6
2023
37
2.170
Why?
Dogs
30
2025
517
1.890
Why?
Osteosarcoma
7
2025
100
1.040
Why?
Neoplasms
6
2024
2954
1.020
Why?
Lymphoma
3
2024
251
0.970
Why?
Cancer Vaccines
2
2025
161
0.910
Why?
Bone Neoplasms
6
2025
272
0.850
Why?
Doxorubicin
5
2024
416
0.830
Why?
Prednisone
4
2024
229
0.820
Why?
Antineoplastic Agents
7
2018
2219
0.780
Why?
Cyclophosphamide
4
2024
275
0.630
Why?
Topoisomerase I Inhibitors
1
2018
20
0.560
Why?
Mammary Neoplasms, Animal
1
2018
35
0.540
Why?
Cats
6
2023
226
0.530
Why?
Animals
35
2025
38106
0.530
Why?
Antibiotics, Antineoplastic
1
2018
141
0.520
Why?
Antineoplastic Agents, Hormonal
1
2018
196
0.500
Why?
Lomustine
2
2024
18
0.500
Why?
Lymphoma, B-Cell
1
2018
150
0.500
Why?
Mastectomy
1
2018
189
0.490
Why?
Prostatic Neoplasms
2
2022
972
0.470
Why?
Ultrasonography
1
2019
788
0.450
Why?
Mastocytosis
1
2015
15
0.440
Why?
Antineoplastic Agents, Alkylating
1
2015
76
0.430
Why?
Veterinary Medicine
1
2014
12
0.420
Why?
Pyrroles
1
2015
222
0.400
Why?
Clinical Trials as Topic
2
2018
1064
0.380
Why?
Antineoplastic Combined Chemotherapy Protocols
4
2024
1998
0.360
Why?
Tongue Neoplasms
1
2012
27
0.360
Why?
Hemangiosarcoma
1
2012
27
0.360
Why?
Protein-Tyrosine Kinases
1
2015
429
0.350
Why?
Mouth Neoplasms
2
2023
88
0.330
Why?
Indoles
1
2015
511
0.330
Why?
T-Lymphocytes, Regulatory
2
2011
415
0.330
Why?
Adenocarcinoma
1
2018
927
0.330
Why?
Vincristine
3
2024
148
0.310
Why?
Soft Tissue Neoplasms
1
2011
133
0.300
Why?
Sarcoma
1
2011
209
0.280
Why?
Pets
2
2021
28
0.270
Why?
Interleukin-15
2
2025
96
0.260
Why?
Proto-Oncogene Proteins c-kit
2
2017
73
0.230
Why?
Listeria
1
2025
5
0.220
Why?
Drug Administration Schedule
4
2016
790
0.220
Why?
Melanoma
2
2022
765
0.210
Why?
Treatment Outcome
11
2025
11821
0.210
Why?
Drug Therapy, Combination
2
2018
1036
0.200
Why?
Chlorambucil
1
2022
11
0.190
Why?
Gastrointestinal Absorption
1
2022
6
0.190
Why?
Retrospective Studies
10
2024
17438
0.180
Why?
Leiomyosarcoma
1
2022
30
0.180
Why?
Area Under Curve
1
2022
335
0.170
Why?
Leiomyoma
1
2022
62
0.170
Why?
Chemotherapy, Adjuvant
3
2025
429
0.170
Why?
Chemoembolization, Therapeutic
1
2022
88
0.170
Why?
Prostatic Hyperplasia
1
2021
40
0.170
Why?
Male
15
2025
73396
0.160
Why?
Maximum Tolerated Dose
2
2018
217
0.160
Why?
Carcinoma
1
2021
225
0.150
Why?
Administration, Oral
1
2022
872
0.150
Why?
Positron Emission Tomography Computed Tomography
1
2020
122
0.150
Why?
Cystectomy
1
2019
46
0.150
Why?
Sirolimus
1
2021
282
0.150
Why?
Education, Veterinary
1
2019
7
0.150
Why?
Carcinoma, Transitional Cell
1
2019
70
0.150
Why?
Kinetics
1
2022
1553
0.140
Why?
Tumor Microenvironment
1
2023
747
0.140
Why?
Embolization, Therapeutic
1
2021
246
0.140
Why?
DNA Topoisomerases, Type I
1
2018
15
0.140
Why?
Neoplasm Recurrence, Local
2
2018
1160
0.140
Why?
Female
13
2025
79499
0.140
Why?
Carcinoma, Hepatocellular
1
2022
370
0.140
Why?
Carboplatin
2
2021
168
0.140
Why?
Authorship
1
2019
51
0.140
Why?
Curcumin
1
2018
29
0.130
Why?
Carcinoma, Squamous Cell
1
2023
628
0.130
Why?
Head and Neck Neoplasms
1
2023
563
0.130
Why?
Catheter Ablation
1
2021
355
0.130
Why?
Prevalence
1
2024
2861
0.130
Why?
Kidney Neoplasms
1
2021
419
0.130
Why?
Mastocytosis, Cutaneous
1
2017
6
0.130
Why?
Bone Marrow
1
2018
310
0.120
Why?
Urinary Bladder Neoplasms
1
2019
259
0.120
Why?
Liposomes
1
2018
269
0.120
Why?
Kaplan-Meier Estimate
1
2018
970
0.120
Why?
Liver Neoplasms
1
2022
776
0.110
Why?
Molecular Targeted Therapy
1
2018
447
0.110
Why?
Interferon Regulatory Factors
1
2015
45
0.110
Why?
Proto-Oncogene Proteins c-bcl-2
1
2016
237
0.110
Why?
Proto-Oncogene Proteins c-myc
1
2016
157
0.110
Why?
Prospective Studies
5
2024
8123
0.110
Why?
Vaccination
1
2023
1449
0.110
Why?
Benzamides
1
2016
226
0.110
Why?
Drug Monitoring
1
2018
399
0.110
Why?
Neovascularization, Pathologic
2
2018
287
0.110
Why?
Lymphoma, Large B-Cell, Diffuse
1
2016
195
0.100
Why?
Uveitis
1
2015
152
0.100
Why?
Gene Expression Regulation, Neoplastic
1
2019
1432
0.090
Why?
Polymerase Chain Reaction
1
2015
1031
0.090
Why?
Dose-Response Relationship, Drug
2
2016
2022
0.080
Why?
Autoimmune Diseases
1
2015
467
0.080
Why?
Leukocytes, Mononuclear
2
2025
585
0.080
Why?
Magnetic Resonance Imaging
2
2022
3926
0.080
Why?
T-Lymphocytes
1
2019
2012
0.080
Why?
Combined Modality Therapy
2
2025
1271
0.080
Why?
Disease Models, Animal
2
2018
4580
0.080
Why?
Immunophenotyping
1
2011
324
0.080
Why?
Neoplasm Metastasis
1
2012
693
0.080
Why?
Lung Neoplasms
1
2022
2675
0.070
Why?
Biopsy
1
2011
1075
0.070
Why?
Prognosis
2
2017
4351
0.070
Why?
Flow Cytometry
1
2011
1163
0.060
Why?
Cohort Studies
2
2019
6077
0.060
Why?
Lymph Nodes
2
2020
511
0.060
Why?
Pilot Projects
1
2011
1888
0.060
Why?
Asparaginase
1
2024
34
0.050
Why?
CD8-Positive T-Lymphocytes
1
2010
931
0.050
Why?
Tetrachlorvinphos
1
2023
1
0.050
Why?
Alanine
1
2024
171
0.050
Why?
Purines
1
2024
188
0.050
Why?
Epidemiologic Studies
1
2023
70
0.050
Why?
Cytokines
2
2025
2081
0.050
Why?
Desmin
1
2022
22
0.040
Why?
Absorbable Implants
1
2022
38
0.040
Why?
Recombinant Proteins
1
2025
1361
0.040
Why?
Microspheres
1
2022
142
0.040
Why?
Laminin
1
2022
72
0.040
Why?
Retroperitoneal Space
1
2021
19
0.040
Why?
Mast Cells
1
2023
150
0.040
Why?
Aggression
1
2023
171
0.040
Why?
Microwaves
1
2021
29
0.040
Why?
Prostate
1
2022
159
0.040
Why?
Paclitaxel
1
2022
260
0.040
Why?
Therapies, Investigational
1
2021
18
0.040
Why?
Urinary Bladder
1
2022
194
0.040
Why?
Arteries
1
2021
261
0.040
Why?
Radiopharmaceuticals
1
2020
210
0.040
Why?
Fluorodeoxyglucose F18
1
2020
164
0.040
Why?
PAX5 Transcription Factor
1
2019
15
0.040
Why?
Scavenger Receptors, Class A
1
2019
13
0.040
Why?
Lymphatic Metastasis
1
2020
335
0.040
Why?
Quality of Life
1
2011
3200
0.040
Why?
Inhibitory Concentration 50
1
2018
90
0.030
Why?
Bibliometrics
1
2019
68
0.030
Why?
Polymers
1
2022
488
0.030
Why?
Forkhead Transcription Factors
1
2019
209
0.030
Why?
Medical Oncology
1
2021
345
0.030
Why?
Humans
7
2025
146342
0.030
Why?
TOR Serine-Threonine Kinases
1
2021
455
0.030
Why?
Publishing
1
2019
117
0.030
Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2019
344
0.030
Why?
Disease Progression
1
2024
2867
0.030
Why?
Periodicals as Topic
1
2019
214
0.030
Why?
Survival Rate
1
2021
2092
0.030
Why?
Retinal Neurons
1
2015
4
0.030
Why?
Sensitivity and Specificity
1
2020
1998
0.030
Why?
Electroretinography
1
2015
51
0.030
Why?
Immunohistochemistry
1
2019
1712
0.030
Why?
Th17 Cells
1
2015
103
0.030
Why?
Poly(ADP-ribose) Polymerase Inhibitors
1
2016
139
0.030
Why?
Gene Deletion
1
2015
385
0.020
Why?
Cell Movement
1
2018
951
0.020
Why?
Skin Neoplasms
1
2020
806
0.020
Why?
Extremities
1
2014
142
0.020
Why?
Triple Negative Breast Neoplasms
1
2016
220
0.020
Why?
T-Lymphocyte Subsets
1
2015
416
0.020
Why?
Sex Factors
1
2019
2107
0.020
Why?
Research Design
1
2019
1143
0.020
Why?
Retina
1
2015
330
0.020
Why?
Microglia
1
2015
289
0.020
Why?
Phosphorylation
1
2017
1724
0.020
Why?
Inflammation Mediators
1
2015
508
0.020
Why?
Mice
2
2022
18297
0.020
Why?
Tomography, X-Ray Computed
1
2021
2786
0.020
Why?
Cell Line, Tumor
1
2018
3545
0.020
Why?
Biomarkers, Tumor
1
2016
1339
0.020
Why?
CD4-Positive T-Lymphocytes
1
2015
1150
0.020
Why?
Risk Factors
1
2023
10921
0.020
Why?
Mice, Knockout
1
2015
3125
0.020
Why?
Signal Transduction
1
2021
5246
0.020
Why?
Severity of Illness Index
1
2015
2921
0.020
Why?
Biomarkers
1
2017
4340
0.010
Why?
Predictive Value of Tests
1
2010
2113
0.010
Why?
United States
1
2021
16136
0.010
Why?
Breast Neoplasms
1
2016
2418
0.010
Why?
Burton's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)